Anti-wrinkle and firming composition containing plant extract as well as preparation method and application of anti-wrinkle and firming composition
By combining Bose with gold button flower extract, aloe vera extract, seaweed extract and coniferous cherry extract, the problem of high cost and slow effect of Bose is solved, and the amount of use is reduced Maintain good anti-wrinkle firming effect underneath, enhance skin elasticity and moisture retention, and promote collagen synthesis and skin repair.
Patent Information
- Application Number
- CN202411328122.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-09-23
AI Technical Summary
Bose is a high cost as an anti-aging active substance and the efficiency rate needs to be improved. It is difficult for the prior art to maintain good anti-wrinkle tightening effects while reducing the amount of Bose.
The compositions including bosein, gold button flower extract, aloe vera extract, seaweed extract and needle cherry extract were prepared by ultrasonic extraction, leaching and wet ultrafine crushing, and used in combination to enhance the Antioxidant, moisturizing and collagen synthesis capabilities of the skin.
In the case of reducing the amount of Bose, the composition can significantly improve the skin's anti-wrinkle firming effect, enhance skin elasticity and moisture retention, promote collagen synthesis and skin repair, and resist external environmental invasion.
Smart Images

Figure BDA0005056014690000011 
Figure BDA0005056014690000021 
Figure BDA0005056014690000022
Abstract
Description
Technical Field
[0001] This invention belongs to the field of skincare technology, specifically relating to an anti-wrinkle and firming composition containing plant extracts, its preparation method, and its application. Background Art
[0002] Pro-Xylane, also known as "Pro-Xylane," is a xylose derivative with anti-aging active ingredients. It's a mixture of glycoproteins derived from xylose. Xylose is abundant in beech trees and promotes the formation of glucosamine polysaccharides (GAGs). As an extract from beech trees, Pro-Xylane shares similarities with xylose in its effects. By promoting the synthesis of glycosamines and increasing dermal collagen production, Pro-Xylane can enhance dermal repair, improve skin elasticity, reduce fine lines, increase skin firmness, and prevent aging, thus contributing to anti-aging effects. However, Pro-Xylane is relatively expensive, and its effectiveness needs improvement. Summary of the Invention
[0003] The purpose of this invention is to provide an anti-wrinkle and firming composition containing plant extracts, which can still have good anti-wrinkle and firming effects while reducing the amount of Brønsted ...
[0004] A second object of the present invention is to provide a method for preparing the above-described composition.
[0005] A third objective of this invention is to provide the application of the above composition in skin care products.
[0006] The purpose of the present invention can be achieved through the following technical solutions:
[0007] The present invention discloses a method for preparing an anti-wrinkle and firming composition containing plant extracts, specifically by uniformly mixing the following components in parts by weight:
[0008]
[0009]
[0010] In a preferred embodiment of the present invention, the composition comprises the following components in parts by weight:
[0011]
[0012] In a preferred embodiment of the present invention, the composition comprises the following components in parts by weight:
[0013]
[0014] As a preferred embodiment of the present invention, the golden button flower extract is obtained by the following operation: the golden button flower is crushed and ultrasonically extracted with cyclohexane to obtain the golden button flower extract.
[0015] As a preferred embodiment of the present invention, the seaweed extract is obtained by the following operation: extracting seaweed with ethanol to obtain the seaweed extract.
[0016] As a preferred embodiment of the present invention, the acerola cherry extract is obtained by the following operation:
[0017] Preparation of acerola cherry pulp: Acerola cherry fruit is used as raw material and crushed by wet ultrafine grinding method to obtain acerola cherry pulp;
[0018] Preparation of acerola cherry extract: Acerola cherry pulp was extracted with an aqueous two-phase mixture of (NH4)2SO4 and ethanol.
[0019] As a preferred embodiment of the present invention, in the preparation of acerola cherry pulp, the wet ultrafine grinding method specifically involves mixing acerola cherries and water at a mass ratio of 1 to 2:3 and then crushing them.
[0020] As a preferred embodiment of the present invention, the specific parameters for preparing acerola cherry extract are as follows: the amount of (NH4)2SO4 per 10 mL of extraction system is 1.66 g, the amount of ethanol is 4.3 mL, the temperature is 40 °C, and the extraction time is 20 min.
[0021] The composition obtained by the above preparation method.
[0022] The above composition is used as an active ingredient in skin care products.
[0023] The beneficial effects of this invention are:
[0024] The composition provided by this invention comprises β-Xylane, *Gynostemma pentaphyllum* extract, aloe vera extract, seaweed extract, and acerola cherry extract. Aloe vera extract can quickly penetrate deep into the skin, providing long-lasting hydration. Acerola cherry extract not only provides abundant vitamin C, promoting collagen synthesis and skin cell regeneration, but also has certain antioxidant and anti-inflammatory effects. The combined use of acerola cherry extract and aloe vera extract provides a comprehensive skincare effect with enhanced moisturizing properties. Furthermore, the combination of acerola cherry extract and seaweed extract enhances the effect of vitamin C in acerola cherry extract in promoting collagen synthesis and skin cell regeneration.
[0025] When a small amount of Pro-Xylane is used in combination with extracts of *Gynostemma pentaphyllum*, aloe vera, seaweed, and acerola cherry, the seaweed and acerola cherry extracts, combined with Pro-Xylane, can enhance the skin's antioxidant capacity, resisting environmental damage, while promoting collagen synthesis and skin repair. The seaweed and aloe vera extracts, combined with Pro-Xylane, can further enhance the skin's antioxidant capacity and improve skin elasticity. *Gynostemma pentaphyllum* extract contains abundant N-alkylamides, which, when combined with a small amount of Pro-Xylane, can exert a good anti-wrinkle effect. The synergistic effect of these ingredients allows Pro-Xylane to maintain its excellent anti-wrinkle and firming effects even with a reduced dosage.
[0026] Furthermore, in the preparation method of acerola cherry extract of the present invention, a wet ultrafine pulverization method + aqueous two-phase extraction method is used, and the resulting acerola cherry extract contains high levels of active ingredients and performs well in efficacy tests. DETAILED DESCRIPTION
[0027] The present invention will be further described in detail below with reference to specific embodiments.
[0028] The aloe extract described below is freeze-dried aloe vera powder, batch number 20150501, which will not be repeated here.
[0029] Example 1
[0030] Preparation of Golden Button Flower Extract
[0031] 80 kg of golden button flowers were crushed and ultrasonically extracted with cyclohexane for 30 min to obtain an extract with a material-to-liquid ratio of 1:20. The extract was then subjected to reduced pressure to recover the solvent and obtain the golden button flower extract.
[0032] Example 2
[0033] Preparation of seaweed extract
[0034] 80 kg of seaweed was soaked and extracted three times with a 25% ethanol solution, each extraction lasting 7 days. The filtrates were combined, concentrated to a paste-like consistency, and finally freeze-dried into a powder form.
[0035] Example 3
[0036] Preparation of acerola cherry extract
[0037] Preparation of acerola cherry pulp: Take 100 kg of acerola cherry fruit as raw material, mix acerola cherry and water at a mass ratio of 1 to 2:3, crush and prepare acerola cherry pulp;
[0038] Preparation of acerola cherry extract: Acerola cherry pulp was further ground using a wet ultrafine mill, with the milling frequency controlled at 30 Hz and the milling time adjusted to 40 s to obtain a pre-slurry. The pre-slurry was then extracted using an aqueous two-phase extraction system of (NH4)2SO4 and ethanol. The extraction was performed with 1.66 g of (NH4)2SO4 and 4.3 mL of ethanol per 10 mL of extraction system, at a temperature of 40 ℃ and an extraction time of 20 min. The two phases after extraction were evaporated and concentrated to remove the solvent, and then mixed to obtain the acerola cherry extract.
[0039] Example 4
[0040] The extracts of golden button flower, seaweed, acerola cherry, aloe vera, and boswellia carterii obtained in Examples 1-3, respectively, were mixed in the following weights to prepare a composition:
[0041]
[0042]
[0043] Example 5
[0044] The extracts of golden button flower, seaweed, acerola cherry, aloe vera, and boswellia carterii obtained in Examples 1-3, respectively, were mixed in the following weights to prepare a composition:
[0045]
[0046] Example 6
[0047] The extracts of golden button flower, seaweed, acerola cherry, aloe vera, and boswellia carterii obtained in Examples 1-3, respectively, were mixed in the following weights to prepare a composition:
[0048]
[0049] Example 7
[0050] The extracts of golden button flower, seaweed, acerola cherry, aloe vera, and boswellia carterii obtained in Examples 1-3, respectively, were mixed in the following weights to prepare a composition:
[0051]
[0052]
[0053] Example 8
[0054] The extracts of golden button flower, seaweed, acerola cherry, aloe vera, and boswellia carterii obtained in Examples 1-3, respectively, were mixed in the following weights to prepare a composition:
[0055]
[0056] Comparative Example 1
[0057] Compared to Example 6, the extract of golden button flower was not added, but was replaced with an equal mass of acerola cherry extract; all other aspects were the same as in Example 6.
[0058] Comparative Example 2
[0059] Compared to Example 6, aloe vera extract was not added, but seaweed extract of equal mass was used instead; all other aspects were the same as in Example 6.
[0060] Comparative Example 3
[0061] Compared to Example 6, no seaweed extract was added; instead, an equal mass of golden button flower extract was used. All other aspects were the same as in Example 6.
[0062] Comparative Example 4
[0063] Compared to Example 6, acerola cherry extract was not added, but was replaced with an equal mass of aloe vera extract; all other aspects were the same as in Example 6.
[0064] The compositions obtained in Examples 4-8 and Comparative Examples 1-4 were tested as follows:
[0065] Experimental Example 1: Fibroblast Anti-wrinkle Index Test
[0066] The fibroblasts were divided into a blank group and a sample group. The sample group was supplemented with the compositions prepared in Examples 4-8 and Comparative Examples 1-4, respectively. The cell count per well was controlled to be 5 × 10⁶. 5 Cells were cultured at 37℃ in a 5% CO2 incubator for 24 hours. The culture medium was then discarded, and a small amount of PBS (pH=7.4) was added, just enough to cover the cells. Cells were then stimulated with UVA at a dose of 7 J / cm². 2 The control group was not irradiated. PBS was discarded, and different concentrations of samples were added. The combined concentration was 6%, VC was 80 μg / mL, and GSH was 20 μm / mL, stimulating cells for 24 h. The cell culture supernatant was centrifuged at 1000g for 15 min at 4℃, and the supernatant was collected. The MMP-1 content was measured using human matrix metalloproteinase-1 (MMP-1) ELISA. The cell suspension was diluted with PBS (pH 7.2–7.4) to achieve a cell concentration of 1 × 10⁻⁶ cells / mL. 6 Cells were repeatedly frozen and thawed to rupture them. After centrifugation at 1000g for 20 min, the supernatant was collected. The CoLI content was tested using a type I collagen (CoI) test kit, and the HA content was tested using a human hyaluronic acid (HA) ELISA kit. All procedures were performed according to the kit instructions. The results are shown in Table 1.
[0067] Table 1
[0068]
[0069] As shown in Table 1, the MMP-1 content of the compositions prepared in Examples 4-8 and Comparative Examples 1-4 was lower than that of the blank group (22.88 ng / mL), indicating that the compositions prepared in Examples 4-8 and Comparative Examples 1-4 could reduce MMP-1 expression in fibroblasts. However, the MMP-1 content of the compositions prepared in Comparative Examples 1-4 was higher than that in Examples 4-8 to varying degrees, indicating that Comparative Examples 1-4 reduced the expression of MMP-1 in fibroblasts to varying degrees.
[0070] The ColI content measured in the compositions prepared in Examples 4-8 and Comparative Examples 1-4 was greater than that in the blank group (5.6 ng / mL), indicating that the compositions prepared in Examples 4-8 and Comparative Examples 1-4 could increase ColI expression. However, the ColI content measured in the compositions prepared in Comparative Examples 1-4 was lower than that in Examples 4-8 to varying degrees, indicating that the effect of Comparative Examples 1-4 on increasing ColI expression was reduced to varying degrees.
[0071] The HA content measured in the compositions prepared in Examples 4-8 and Comparative Examples 1-4 was 5.3 ng / mL higher than that in the blank group, indicating that the compositions prepared in Examples 4-8 and Comparative Examples 1-4 could increase the HA content of fibroblasts and reverse the decrease in HA caused by UVA radiation. However, the HA content measured in the compositions prepared in Comparative Examples 1-4 was lower than that in Examples 4-8 to varying degrees, indicating that the effect of Comparative Examples 1-4 in reversing the decrease in HA caused by UVA radiation was reduced to varying degrees.
[0072] The compositions obtained in Examples 4-8 and Comparative Examples 1-4 were prepared into an eye cream according to the following procedure, and then human trials were conducted:
[0073] (1) Pre-disperse carbomer in water, and after it is evenly dispersed, add other raw materials of phase B, place it in a water bath, control the temperature at 75-80℃, and stir at a constant speed for about 30 minutes until it is completely dissolved to obtain mixture B.
[0074] (2) Weigh the A phase raw material into a beaker, place it in a water bath, control the temperature at 75-80℃, stir at a uniform speed for about 30 minutes, and obtain oily material A after it is completely dissolved.
[0075] (3) Mix the raw materials of phase C thoroughly to obtain mixture C;
[0076] (4) Add water to the D phase raw material to prepare a 2wt% water mixture as the mixture D;
[0077] (5) Pour mixture B into A, control the temperature within the range of 75-80℃ and stir rapidly for 30 minutes, then reduce the temperature to 40-45℃ and add mixtures C and D. Then reduce the temperature to 30-35℃, stop stirring and discharge the material to obtain the eye cream.
[0078] Table 2
[0079]
[0080] Experiment Example 2: Human Trial
[0081] The eye creams prepared in Examples 4-8 and Comparative Examples 1-4 were used in human trials, and the specific procedures are as follows:
[0082] Volunteer inclusion criteria: ① Healthy Chinese female subjects aged 34-65 years; ② "Crow's feet" grade ≥2 points, according to the standards in "Skin Aging Atlas Volume 2 Asian Type"; ③ Have not participated in other skin care products or clinical studies within 1 month; ④ Signed informed consent form.
[0083] Exclusion criteria: ① Women planning to become pregnant, pregnant, breastfeeding, or within 6 months postpartum; ② Individuals with severe systemic diseases, immunodeficiency, or autoimmune diseases; ③ Individuals with allergic diseases or who have had cosmetic allergies within the past 1-2 years; ④ Individuals currently using anti-wrinkle products or undergoing cosmetic treatments or participating in other tests on the test site within the past month; ⑤ Individuals with dermatological diseases in the test area or currently receiving drug treatment; ⑥ Individuals with diseases that may affect the test or who are undergoing treatments that may affect the test; ⑦ Individuals deemed unsuitable for participation by the researchers.
[0084] The test procedure is as follows:
[0085] 1. For skin application
[0086] After cleansing, volunteers applied an appropriate amount of eye cream around their eyes, gently massaging until absorbed. They applied it twice daily, morning and evening, for 30 consecutive days. A test was conducted before use and again after one month.
[0087] 2. Instrument Testing
[0088] (1) Cleanse your eyes with water and sit quietly in the room for at least 15 minutes.
[0089] (2) The skin elasticity index R2 of the eyes was measured before and after use using a skin elasticity meter. The average value was taken after 3 measurements. The results are shown in Table 3. The R2 value is the ratio of the skin's rebound amount without negative pressure to the maximum stretch amount with negative pressure. The closer the R2 value is to 1, the better the skin elasticity.
[0090] (3) The glossiness of the eye area before and after use was measured using a skin glossiness measuring probe. The average value was taken after three measurements. The results are shown in Table 3. The higher the glossiness value, the better the skin glossiness.
[0091] (4) Use a skin moisture measuring probe to detect the moisture of the skin around the eyes before and after use. Take the average value after 10 measurements. The results are shown in Table 3.
[0092] Table 3
[0093]
[0094] As shown in Table 3, in the human trials, the R² values measured before using the eye cream in Examples 4-8 and Comparative Examples 1-4 were all less than 0.62, and the R² values after use were all greater than 0.62. The eye creams prepared in Examples 4-8 and Comparative Examples 1-4 all achieved R² values close to 1, indicating that they all have the effect of enhancing skin elasticity. However, the R² values measured after use for the eye creams prepared in Comparative Examples 1-4 were all lower than those in Examples 4-8 to varying degrees, indicating that the skin elasticity-enhancing effects of Comparative Examples 1-4 were reduced to varying degrees.
[0095] Before using the eye cream, the moisture content of the skin around the eyes in Examples 4-8 and Comparative Examples 1-4 was less than 64%, while after use, it was greater than 64%, indicating that the eye creams prepared in Examples 4-8 and Comparative Examples 1-4 all have the effect of enhancing skin moisture. However, the moisture content of the skin around the eyes after using the eye creams prepared in Comparative Examples 1-4 was lower than that in Examples 4-8 to varying degrees, indicating that the effect of Comparative Examples 1-4 in enhancing skin moisture was reduced to varying degrees.
[0096] The above description is merely an embodiment of the present invention and does not limit the scope of patent protection. Any non-substantial changes or substitutions made by those skilled in the art based on the present invention will still fall within the scope of patent protection.
Claims
1. A method for preparing an anti-wrinkle and firming composition containing plant extracts, characterized in that: Specifically, the following components in parts by weight are mixed uniformly:
2. The preparation method according to claim 1, characterized in that The composition comprises the following components in parts by weight:
3. The preparation method according to claim 1, characterized in that The composition comprises the following components in parts by weight:
4. The preparation method according to claim 1, characterized in that The jambu flower extract is prepared by the following operations: crushing the jambu flower, and performing ultrasonic extraction with cyclohexane to prepare the jambu flower extract.
5. The preparation method according to claim 1, characterized in that The seaweed extract is prepared by the following operation: extracting the seaweed with ethanol to obtain the seaweed extract.
6. The preparation method according to claim 1, characterized in that The acerola cherry extract is prepared by the following operations: Preparation of acerola cherry pulp: taking acerola cherry fruit as raw material, crushing it by wet ultrafine grinding method to obtain acerola cherry pulp; Preparation of acerola cherry extract: Acerola cherry pulp was extracted with a two-phase aqueous solution formed by (NH4)2SO4 and ethanol.
7. The preparation method according to claim 6, characterized in that In the preparation of acerola cherry pulp, the wet ultrafine grinding method specifically comprises: mixing acerola cherry and water in a mass ratio of 1 to 2:3 and crushing the mixture.
8. The preparation method according to claim 6, characterized in that The specific parameters for preparing the acerola cherry extract are: extraction with 1.66 g of (NH4)2SO4 per 10 mL of the extraction system, 4.3 mL of ethanol, a temperature of 40°C, and an extraction time of 20 min.
9. The composition obtained by the preparation method according to any one of claims 1 to 8.
10. Use of the composition prepared by the preparation method according to any one of claims 1 to 8 as an effective component in skin care products.
Citation Information
Patent Citations
Beautifying anti-aging food taking acerola cherry extract, haematococcus pluvialis and fish collagen peptide as raw materials and preparation method thereof
CN107549812A
Anti-ageing anti-wrinkling tightening essential oil
CN109568209A
Anti-wrinkle firming polypeptide composition and application thereof
CN117338627A
Shaped steel with strength and stiffness
KR1020210117406A
